Skip to main content
Signal8

Noveris Health Sciences Inc. (MYCOF)

Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013, the company maintains its headquarters in Vancouver, Canada.

Sector: Medical - Pharmaceuticals

Industry: Medical - Pharmaceuticals

Noveris Health Sciences Inc. logo

Noveris Health Sciences Inc.

OTC:MYCOFHealthcare
Mkt Cap-
EV-
Float54.67M
O/S58.55M
Inst Own-
Net Cash/Sh-$0.11
Dilution
Financials Summary
Revenue$0
Net Income$2.04M
Total Assets$7K
Free Cash Flow$7K
Debt & Equity
Total Debt$6.71M
Total Equity-$8.73M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
2-year cumulative
1:50

Nasdaq bars a compliance period at 1:250

  1. 1:50Reverse split
    Oct 21, 202550 shares → 1
  2. 1:50Reverse split
    Apr 21, 202250 shares → 1
Balance Sheet Details
Assets$7K
Liabilities$8.74M
Accounts Receivable$0
Accounts Payable$1.34M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$0$0$0$0$5K$2K$88K$145K$0$0$59K$59K$34K$0
YoY Growth----186.3%-97.9%-39.5%---0.0%71.4%--
Cost of Revenue$0$0$7K$90K$0$0$66K$77K$173K$1.24M$1.38M$0$0$0
Gross Profit$0$0-$7K-$90K$5K$2K$22K$68K-$173K-$1.24M-$1.32M$59K$34K$0
Gross Margin----100.0%100.0%25.1%47.1%---2243.4%100.0%100.0%-
Research and Development-$28K$0$759K$2.51M$2.77M$903K$0$0$0$0$738$0$0$0
Selling, General, and Administrative$302K$1.74M$5.81M$6.99M$10.32M$7.05M$2.34M$3.93M$10.72M$2.92M$2.58M$575K$32K$9
Other$111K$0$0$1.5M$2.38M-$111K$105K-$3.17M-$69K-$3K-$2K$0$0$0
Total Operating Expenses$385K$1.74M$6.57M$11M$15.47M$7.84M$2.44M$4.13M$10.99M$2.93M$2.66M$651K$51K$29
Operating Income (EBIT)-$385K-$1.74M-$6.57M-$11M-$15.47M-$7.85M-$2.32M-$4.06M-$10.99M$2.93M$2.61M$777K$17K-$29
Operating Margin-----294931.0%-428262.5%-2642.2%-2792.7%--4430.5%1320.6%49.3%-
Interest Expense$153K$1.01M$912K$638K$144K$128K$48K$49K$5K$33K$75K$21K$23K$0
Interest Income$0$0$0$638$0$0$0$13K$0$0$53$5$71$31
Other Income (Expense)$2.43M-$467K-$8.09M-$25K-$1.04M-$10.97M-$12.62M-$5.28M-$1.39M-$2.65M-$185K-$325K-$58K-$32
Income Before Tax (EBT)$2.04M-$2.21M-$14.66M-$11.02M-$16.51M-$18.86M-$2.46M-$9.35M-$12.29M-$5.57M-$3.25M-$858K-$75K-$60
Income Tax Expense$0$0$0-$3.78M$0$426K$154K$49K$5K-$214K$75K$21K$23K$0
Net Income$2.04M-$2.21M-$14.66M-$8.29M-$20.23M-$18.86M-$2.61M-$9.35M-$12.29M-$5.32M-$3.25M-$858K-$75K-$60
Net Income Margin-----385658.6%-1029764.8%-2968.2%-6431.4%---5524.0%-1459.0%-219.6%-
Supplementary Data
EPS2.37-0.05-0.68-1.37-6.17-11.82-8.37-122.07-311.45-243.37-191.20-58.15-44.080.00
Diluted EPS2.37-0.05-0.68-1.37-6.17-11.82-8.37-122.07-311.15-243.37-191.20-58.15-44.080.00
Weighted Average OS1.24M59.63M30.70M8.65M4.68M2.27M445,465109,40656,37431,24824,26921,0762,4410
EBITDA$2.2M-$1.73M-$6.57M-$11M-$16.2M-$7.95M-$14.91M-$4.04M-$10.82M-$2.93M-$2.68M-$820K$1K$19K
EBITDA Margin-----308854.5%-434025.9%-16964.3%-2782.2%---4557.2%-1394.2%2.9%-
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$7K$228$26K$8K$1.05M$1.53M$13K$8K$1.66M$394K$70K$61K$4K$25
Short-Term Investments$0$0$0$4.87M$0$0$0$0$0$0$0$0$0$35K
Cash and Short-Term Investments$7K$228$26K$4.87M$1.05M$1.53M$13K$8K$1.66M$394K$70K$61K$4K$35K
Accounts Receivable$0$35K$109K$254K$143K$29K$8K$0$0$0$18K$1K$0$0
Inventory$0$0$0$0-$143K$33K$351K$6K-$198K$0-$73K-$1K$0$0
Other Current Assets$0$0$0$0$143K$0$0$0$0$0$0$8K$0$0
Total Current Assets$7K$35K$149K$5.98M$3.66M$1.75M$421K$345K$1.86M$394K$88K$75K$4K$35K
Long-Term Assets
Property, Plant & Equipment Net$0$0$0$7K$396K$361K$49K$3.23M$48K$814K$1.33M$879K$896K$1.37M
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$3.49M$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$3.57M$922K$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0-$922K$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$475K$1.26M$993K$3.23M$69K$45K$644K$762K$455K$455K$0
Total Long-Term Assets$0$0$0$482K$1.65M$4.93M$6.77M$3.3M$93K$1.46M$2.09M$1.33M$1.35M$1.37M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$7K$35K$149K$4.83M$5.31M$6.67M$7.19M$3.65M$1.95M$1.85M$2.18M$1.41M$1.36M$1.4M
Liabilities
Current Liabilities
Accounts Payable$1.34M$4.94M$4.6M$3.59M$463K$589K$95K$55K$43K$31K$74K$14K$4K$8K
Short-Term Debt$6.61M$4.81M$3.8M$60K$44K$2.07M$0$1.22M$6K$41K$994K$12K$12K$0
Current Income Tax Payable$14K$26K$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0$0$0$504K$239K$0$0
Other Current Liabilities$253K$0$0$269K$896K$1.35M$0$0$0$0$5K$5K$0$1.64M
Total Current Liabilities$9K$10K$8.49M$4.06M$2.06M$4.06M$145K$1.29M$1.02M$866K$1.58M$271K$30K$1.65M
Long-Term Liabilities
Long-Term Debt$99K$0$0$3.29M$3.05M$0$0$0$49K$58K$706K$1.07M$666K$485K
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$57K$0$0$0$0$0$0$0$0$0$0$0$5K$1
Total Long-Term Liabilities$156K$0$0$3.29M$3.1M$117K$17K$0$49K$58K$706K$1.07M$670K$485K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$8.74M$10.48M$8.49M$7.35M$5.16M$4.18M$162K$1.29M$1.07M$924K$2.28M$1.34M$701K$2.13M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$1$0$0$0$0
Common Stock$88.39M$88.39M$88.29M$81.14M$75.37M$59.71M$34.87M$28.33M$17.76M$8.04M$3.74M$1.34M$1.4M$0
Retained Earnings-$108.4M-$110.79M-$108.58M-$95.54M-$87.44M-$66M-$32.91M-$30.46M-$21.11M-$8.82M-$4.91M-$1.66M-$802K-$726K
Comprehensive Income & Other$0$0$200K$123K$123K-$311K$386-$39K$88K$0$0$77K$0$0
Other Stockholders' Equity$11.28M$11.95M$11.95M$11.87M$12.23M$8.78M$5.07M$4.48M$4.23M$1.7M$1.06M$380K$53K$1
Total Equity-$8.73M-$10.45M-$8.34M-$2.52M$148K$2.49M$7.03M$2.35M$878K$928K-$106K$65K$655K-$726K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$7K$35K$149K$4.83M$5.31M$6.67M$7.19M$3.65M$1.95M$1.85M$2.18M$1.41M$1.36M$1.4M
Supplementary Data
Total Debt$6.71M$4.81M$3.8M$3.35M$3.15M$2.24M$44K$1.22M$55K$99K$1.7M$1.09M$677K$485K
Net Debt$7K$5K$3.77M$3.34M$2.1M$704K$31K$1.21M-$1.6M-$295K$1.63M$1.02M$673K$485K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income$2.04M-$2.21M-$14.66M-$12.07M-$16.51M-$18.86M-$2.46M-$9.35M-$12.29M-$5.57M-$3.25M-$858K-$75K-$60K
Depreciation & Amortization$0$7K$7K$90K$165K$40K$32K$15K$173K$6K$17K$18K$18K$19K
Deferred Income Tax$0$0$0$0$336K$3.24M$40K$118K$1.33M$2.75M$453K$117K$0$0
Stock-Based Compensation$0$0$0$0$2.17M$1.74M$1.12M$1.82M$6.73M$1.44M$1.67M$100K$0$0
Changes in Working Capital:
  Accounts Receivable$0$135K$145K-$58K-$3K-$19K-$971$0$0$0$806-$806$0$0
  Inventory$0$0$0-$3.49M-$488K$536-$25K-$6K$0$0$0$0$0$0
  Accounts Payable$0$0$0$3.49M$488K$1.31M$87K$0$293K$247K$316K$0$0$0
  Other Working Capital$23K$148K$3.56M$5.81M-$3.21M-$52K$79K-$348K$293K$73K-$68K$244K$23K$0
Total Working Capital Change$23K$148K$3.71M$5.75M-$3.22M$1.24M$140K-$353K$293K$320K$330K$243K$23K$0
Other Non-Cash Items-$2.06M$2.03M$8M$332K$217K$7.62M$81K$4.96M$56K$22K$183K$304K$37K$204
Net Cash from Operating$7K-$26K-$2.95M-$5.9M-$16.84M-$4.99M-$1.04M-$2.79M-$3.71M-$1.03M-$597K-$77K$3K-$41K
Investing Activities
Capital Expenditures$0$0$0-$25K-$283K-$368K-$36K-$6K-$67K-$517K-$435K-$8K$0$0
Acquisitions$0$0$0-$1K$0$353K$0-$64K-$45K-$16K-$42$73$0$0
Purchases of Investments$0$0$0$0-$48K-$220K$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$220K$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$368K$0$0-$386K$74K-$112K-$266K$71K-$150K$72K$0$0
Net Cash from Investing$0$0$368K-$26K-$332K-$401K$39K-$183K-$378K-$446K-$585K$64K$0$0
Financing Activities
Debt Repaid-----$3.85M-$3.22M-$744K$35K$106K-$390K$99K$12K-
Common Stock Issuance$0$0$2.53M$4.84M$10.73M$3.28M$460K$1.95M$18K$476K$420K$91K$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$0$0$2.1M$443K$543K$2.11M$5.38M$1.44M$381K$77K$12K$43K
Net Cash from Financing$0$0$2.6M$4.89M$16.68M$6.95M$1M$1.36M$5.36M$1.8M$1.19M$69K$807$43K
Forex Effect$0$0$0$0$0-$37K$4K-$37K$0$0$0$0$0$0
Net Change in Cash$7K-$26K$19K-$1.04M-$487K$1.52M$5K-$1.65M$1.27M$324K$9K$57K$4K$1K
Supplementary Data
Operating Cash Flow$7K-$26K-$2.95M-$5.9M-$16.84M-$4.99M-$1.04M-$2.79M-$3.71M-$1.03M-$597K-$77K$3K-$41K
Capital Expenditure$0$0$0-$25K-$283K-$368K-$36K-$6K-$67K-$517K-$435K-$8K$0$0
Free Cash Flow$7K-$26K-$2.95M-$5.92M-$17.12M-$5.35M-$1.08M-$2.8M-$3.78M-$1.54M-$1.03M-$85K$3K-$41K
Cash at Beginning$228$26K$8K$1.05M$1.53M$13K$8K$1.66M$394K$70K$61K$4K$25-$1K
Cash at End$7K$228$26K$8K$1.05M$1.53M$13K$8K$1.66M$394K$70K$61K$4K$25